Clinical Trial Update: Genetics of QT Response to Moxifloxacin [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating the genetics of QT response to moxifloxacin was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrhythmias

Drugs mentioned

• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Cardiac Arrhythmias | Phase 4 | Status: TERMINATED